Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrei V Blokhin

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Archives of Biochemistry and Biophysics|January 24, 2009
Evidence for a distinct ligand binding site on tubulin discovered through inhibition by GDP of paclitaxel-induced tubulin assembly in the absence of exogenous GTPElizabeth Wilcox, Connor McGrath, Andrei V Blokhin, et al.
Journal of Visualized Experiments : Jove|December 7, 2011
Imaging of estrogen receptor-α in rat pial arterioles using a digital immunofluorescent microscopeNiloofar Rezvani, Andrei V Blokhin, Emil Zeynalov, et al.
Bioconjugate Chemistry|June 18, 2010
Hybrid PET/CT for noninvasive pharmacokinetic evaluation of dynamic PolyConjugates, a synthetic siRNA delivery systemSarah R Mudd, Vladimir S Trubetskoy, Andrei V Blokhin, et al.
Bioorganic & Medicinal Chemistry|August 21, 2003
Long-chain polyamines (oligoamines) exhibit strong cytotoxicities against human prostate cancer cellsAldonia Valasinas, Venodhar K Reddy, Andrei V Blokhin, et al.
Journal of Medicinal Chemistry|October 3, 2003
Cyclopropane-containing polyamine analogues are efficient growth inhibitors of a human prostate tumor xenograft in nude miceBenjamin Frydman, Andrei V Blokhin, Sara Brummel, et al.
The Journal of Organic Chemistry|October 25, 2001
Manifestations of Bridgehead-Bridgehead Interactions in the Bicyclo[1.1.1]pentane Ring SystemWilliam Adcock, Andrei V. Blokhin, Gordon M. Elsey, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2007
Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytesDavid B Rozema, David L Lewis, Darren H Wakefield, et al.
Molecular Cancer Therapeutics|October 29, 2017
HIF2α-Targeted RNAi Therapeutic Inhibits Clear Cell Renal Cell CarcinomaSo C Wong, Weijun Cheng, Holly Hamilton, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 19, 2015
Protease-triggered siRNA delivery vehiclesDavid B Rozema, Andrei V Blokhin, Darren H Wakefield, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Archives of Biochemistry and Biophysics|January 24, 2009
Evidence for a distinct ligand binding site on tubulin discovered through inhibition by GDP of paclitaxel-induced tubulin assembly in the absence of exogenous GTPElizabeth Wilcox, Connor McGrath, Andrei V Blokhin, et al.
Journal of Visualized Experiments : Jove|December 7, 2011
Imaging of estrogen receptor-α in rat pial arterioles using a digital immunofluorescent microscopeNiloofar Rezvani, Andrei V Blokhin, Emil Zeynalov, et al.
Bioconjugate Chemistry|June 18, 2010
Hybrid PET/CT for noninvasive pharmacokinetic evaluation of dynamic PolyConjugates, a synthetic siRNA delivery systemSarah R Mudd, Vladimir S Trubetskoy, Andrei V Blokhin, et al.
Bioorganic & Medicinal Chemistry|August 21, 2003
Long-chain polyamines (oligoamines) exhibit strong cytotoxicities against human prostate cancer cellsAldonia Valasinas, Venodhar K Reddy, Andrei V Blokhin, et al.
Journal of Medicinal Chemistry|October 3, 2003
Cyclopropane-containing polyamine analogues are efficient growth inhibitors of a human prostate tumor xenograft in nude miceBenjamin Frydman, Andrei V Blokhin, Sara Brummel, et al.
The Journal of Organic Chemistry|October 25, 2001
Manifestations of Bridgehead-Bridgehead Interactions in the Bicyclo[1.1.1]pentane Ring SystemWilliam Adcock, Andrei V. Blokhin, Gordon M. Elsey, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2007
Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytesDavid B Rozema, David L Lewis, Darren H Wakefield, et al.
Molecular Cancer Therapeutics|October 29, 2017
HIF2α-Targeted RNAi Therapeutic Inhibits Clear Cell Renal Cell CarcinomaSo C Wong, Weijun Cheng, Holly Hamilton, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 19, 2015
Protease-triggered siRNA delivery vehiclesDavid B Rozema, Andrei V Blokhin, Darren H Wakefield, et al.
Pageof 1